Pembrolizumab-associated Guillain-Barre syndrome in a patient with endometrial cancer: A case report

Objective: Guillain–Barré syndrome (GBS) is a rare yet potentially life-threatening adverse event of immune checkpoint inhibitors (ICI). It classically presents with ascending symmetric weakness, areflexia, and distal sensory loss. We present a case of pembrolizumab-induced GBS in a patient with adv...

Full description

Saved in:
Bibliographic Details
Main Authors: Emily Gleason, Meridith Pollie, Sanjana Satish, Sue Li, Janos L. Tanyi
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Gynecologic Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578925001419
Tags: Add Tag
No Tags, Be the first to tag this record!